Aurora BioSystems was established in 2008 by an international science and technology group that is highly networked in advanced technologies of life science research. The focus is to provide worldwide high-quality products for life science research and to develop new cutting-edge technologies for innovative research. The company is positioned to provide a broad array of human, mouse, and rat antibodies and cytokines. Through a number of life science alliances Aurora is able to develop first in class cytokines, custom antibodies, stem cell culture products, and products for closed system adherence capabilities. Due to the high-level of a First Class International Network it was possible to build up initially over 500 strong product offerings of cytokines and antibodies within one year after founding the company. These advantages offer the possibilities to develop, produce, and market further innovative products and technologies of the highest quality within a short time and shared cost benefits. Aurora BioSystems is looking further to intensify these collaborations of academia and industry. The products are distributed worldwide through an international experienced service team and distributors. Due to the need of innovation in Life Science Research and clinical outcome for patients, Aurora BioSystems offers the possibility to build up cooperation within the Biotechnology, Medical Technology, and Pharmaceutical Industry. Not only is our aim to bring innovative products to the market, our goal goes much further to combine complementary products to even more advanced technologies for the benefit of Life Science Research in Cellular Therapeutics, new emerging technologies, adjuvants, and better treatments for patients.